SEP 23, 2026 · JOURNAL ARTICLE
Bipolar androgen therapy in castration-resistant prostate cancer: Biological rationale, clinical evidence, and future directions
Current Urology
Androgen deprivation therapy remains the cornerstone of systemic treatment for advanced prostate cancer. However, progression to castration-resistant prostate cancer (CRPC) is almo